Weekly Call Stock Options

These Option Premium Ratios were generated on January 7th, 2018 and last modified on January 7th, 2018.

Page 1 of 20
Symbol Name Exchange Expiry
OSTK OVERSTOCK.COM NASDAQ 2018-01-12 5.01
RIOT RIOT BLOCKCHAIN INC. COMMON STOCK NASDAQ 2018-01-12 4.85
GOOS CANADA GOOSE HOLDINGS INC NYSE 2018-01-12 4.44
SAGE SAGE THERAPEUTICS INC. COMMON NASDAQ 2018-01-12 4.30
ROKU ROKU INC. CLASS A COMMON STOCK NASDAQ 2018-01-12 3.69
GME GAMESTOP NYSE 2018-01-12 3.64
VNET 21VIANET GROUP NASDAQ 2018-01-12 3.49
SRPT SAREPTA THERAPEUTICS INC. COM NASDAQ 2018-01-12 3.49
MNK MALLINCKRODT PUBLIC LIMITED CO NYSE 2018-01-12 3.49
EXAS EXACT SCIENCES NASDAQ 2018-01-12 3.45
W WAYFAIR INC NYSE 2018-01-12 3.25
HIMX HIMAX TECHNOLOGIES NASDAQ 2018-01-12 3.00
AKS AK STEEL HOLDING NYSE 2018-01-12 2.95
ACAD ACADIA PHARMACEUTICALS NASDAQ 2018-01-12 2.94
GPRO GOPRO INC. CLASS A COMMON STO NASDAQ 2018-01-12 2.93
ENDP ENDO INTERNATIONAL PLC ORDINAR NASDAQ 2018-01-12 2.93
NBR NABORS INDUSTRIES NYSE 2018-01-12 2.92
RH RESTORATION HARDWARE NYSE 2018-01-12 2.92
ARNA ARENA PHARMACEUTICALS NASDAQ 2018-01-12 2.91
VRX VALEANT PHARMACEUTICALS NYSE 2018-01-12 2.91


We are not financial advisors, and none of the information on this website (FatPremiums.com) can be considered financial advice. Options involve risk and are not suitable for all investors. The information on this website is provided solely for general education and information purposes and therefore should not be considered complete, precise, or current. No statement within the website should be construed as a recommendation to buy or sell a security or to provide investment advice. Principals of FatPremiums.com may or may not hold long or short positions in securities, such as weekly options, stocks, exchange-traded funds, future options and futures discussed herein at any time.

Please read our Terms and Conditions for more information, along with our Privacy Policy before using this site.

More information about Sources, Credits, Licenses & Attributions of content used on this site.

Questions, criticisms or comments? Please contact us.